The German Advisory Committee Blood (Arbeitskreis Blut) provides scientific advice to the government concerning the safety and efficient use of blood and blood products. A major focus is the safety regarding transmission of infectious agents. In the last 20-30 years, the safety of blood and blood products has increased dramatically and has meanwhile reached very high levels which not even optimistic scientists had predicted at that time. This rapid increase in pathogen safety is due to strict donor selection criteria and increasingly more sensitive and specific tests used for donor screening. Not only tests for the detection of antibody or antigens have been improved but particularly the introduction of nucleic acid amplification technology led to major progress and reduction in the number of window period donations. Patients and the general public expect an elimination of virtually any risk involved in transfusion. However, unfortunately a 'zero risk' cannot be reached with biological products. In addition, new agents emerge and pose additional risks for transmission because they are not identified by the established screening systems, or there is no feasible test available yet, e.g. for the agent causing variant Creutzfeldt-Jakob disease. Because of the importance of blood borne infections, the Arbeitskreis Blut established a special working group dedicated to compiling and updating information on infectious agents transmitted by blood. This series of reviews differs from a conventional review on a given pathogen because it is focused strongly on the perspective for blood transfusion. Therefore, these articles cover not only the characteristics of the infectious agent and the corresponding disease but also emphasize the epidemiology as well as the presence of a pathogen in the peripheral blood and detection systems. In addition, they provide information as to the reduction or elimination of infectious agents during the plasma fractionation process and their sensitivity to inactivation procedures. The various aspects are covered both from the point of view of the donor and from that of the recipient, particularly the transmissibility. Finally, the articles make a clear recommendation on measures to be taken (or -alternatively -not to be taken). The frequent request from blood banks or scientific societies, etc. to provide this information on these blood borne pathogens in a single issue of a journal or booklet in order to have the relevant information ready at hand is now met with the present issue of TRANSFUSION MEDICINE AND HEMO-THERAPY. It contains all articles on transfusion-transmitted pathogens published by the Arbeitskreis Blut between 1998 and 2005. It also includes two recent articles on Q-fever (Coxiella burnetii) and variant Creutzfeldt-Jakob disease. These two articles are published in the present issue in their English version for the first time. The various articles include the latest developments available at the time of publication. They critically evaluate the risk potential and recommend appropriate measures based on the risk evaluation. The goal is to provide an independent assessment, based on scientific criteria and not influenced by the sometimes over-exaggerated putative threats found in the media. Of course, the cost-benefit ratio is considered in such a critical evaluation. These recommendations frequently provide the basis for the introduction of new additional tests or also for abolishing certain screening systems (e.g. p24 assay). The articles attempt to point out new developments (e.g. the availability of new screening systems) and warn against tendencies leading to new or higher risk for a given pathogen. The collection of articles covers both viral and bacterial agents and, of course, prion diseases. It also includes articles on viruses (GB virus type C, TT virus), which were initially considered as a potential threat but finally found to be ubiquitous and not associated with a specific disease although they are transmissible by blood. The working group Assessment of Pathogens Transmissible by Blood meets regularly at the Paul-Ehrlich-Institut and in-cludes members of the Arbeitskreis Blut and also specialists from the corresponding scientific societies. Additional experts are occasionally included in the preparation of individual reports, and their special expertise proved to be valuable. The Arbeitskreis Blut recognizes and is grateful for the efforts made by this group in the preparation of the detailed manuscripts. In addition, the contribution of the secretaries involved (Ms. Knoess 
